Business Context and Reporting Period
Company: Wearable Devices Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Month of December 2025 (Filing Date: December 1, 2025)
Principal Office: Yokne-am Illit, Israel
This filing reports a material warrant inducement transaction and an increase in the company's equity incentive plan pool. The company operates in the wearable devices, cybersecurity, and telecom sectors.
Key Financial Metrics and Transaction Details
Transaction Proceeds: The Company expects to receive aggregate gross proceeds of approximately $5.68 million from the exercise of existing warrants by a specific holder.
Use of Proceeds: Net proceeds are intended for working capital and general corporate purposes.
Transaction Costs:
- Financial Advisor Fee: 8.0% of aggregate gross proceeds.
- Legal Fees: Up to $25,000 payable to the Financial Advisor.
Capital Structure Changes:
- Existing Warrants Exercised: 3,322,000 ordinary shares at an exercise price of $1.71 per share.
- New Warrants Issued: Up to 5,813,500 ordinary shares at an exercise price of $1.86 per share.
- Option Pool Increase: The Board approved an increase in shares reserved for the 2024 Global Equity Incentive Plan from 795,252 to 2,473,856 (an increase of 1,678,604 shares).
Liquidity and Debt: The filing text does not provide specific values for total revenue, net profit, operating cash flow, margins, total debt, or current liquidity ratios. The transaction is designed to improve working capital.
Material Changes and Transaction Terms
The primary material change is the "Warrant Inducement Transaction" entered into on November 26, 2025. Key terms include:
- Closing Date: Expected on or about December 1, 2025, subject to customary conditions.
- Shareholder Approval: Required for the issuance of New Warrants. The Company must hold a meeting within 90 days of the Closing Date to obtain this approval.
- Exercisability: New Warrants are exercisable immediately upon Shareholder Approval and expire five years thereafter.
- Ownership Caps: Holders cannot exercise warrants to own more than 4.99% (or up to 9.99% at election) of outstanding shares, with a hard cap of 24.99% beneficial ownership.
- Registration: Resale of shares from existing warrants is registered under Form F-3. A new registration statement (Form F-1 or F-3) for New Warrant shares must be filed within 30 days of Shareholder Approval.
Outlook, Risks, and Contingencies
Management Commentary: The Company intends to use the proceeds to support working capital needs. The transaction is contingent on shareholder approval and the satisfaction of closing conditions.
Risks and Contingencies:
- Shareholder Approval Risk: If approval is not obtained at the first meeting, the Company must call meetings every 90 days until approval is granted or warrants are no longer outstanding.
- Liquidity of Warrants: There is no established trading market for the New Warrants, and liquidity is expected to be extremely limited.
- Forward-Looking Statements: Actual results may differ materially due to market acceptance, competition, regulatory compliance, and the ability to meet operating costs.
- Variable Rate Transaction Lock-up: The Company agreed not to effect any Variable Rate Transaction for 30 days following the inducement letter date.
Investor Verification Checklist
- Verify the status of the Shareholder Approval required for the issuance of the 5,813,500 New Warrants.
- Confirm the actual net proceeds received after deducting the 8.0% financial advisor fee and legal costs.
- Monitor the filing of the Resale Registration Statement (Form F-1 or F-3) for the New Warrant Shares within the required 30-day window post-approval.
- Review the impact of the 1,678,604 share increase in the option pool on future dilution.
- Check for any subsequent filings regarding the 4.99% or 9.99% beneficial ownership limits and whether the holder has elected to increase their cap.